Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Pradhan

P3.01-06 Concomitant Plasma-Genotyped T790M Positivity and Small Cell Carcinoma Transformation in EGFR-Mutated NSCLC

Journal of Thoracic Oncology

English

(173) Neuropathic Pain Creates an Enduring Deficit in Prefrontal Cortex-Dependent Behavioral Performance That Is Resistant to Gabapentin Treatment but Reversed by Metformin

English

Related publications

Squamous Cell Carcinoma “Transformation” Concurrent With Secondary T790M Mutation in Resistant EGFR -Mutated Adenocarcinomas

Journal of Thoracic Oncology

English

P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC

Journal of Thoracic Oncology

English

P3.01-11 Depression and Inflammation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.13-13 Real-World Study of Osimertinib in EGFR T790m-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis

Journal of Thoracic Oncology

English

Primary Concomitant EGFR T790M Mutation Predicted Worse Prognosis in Non-Small Cell Lung Cancer Patients

OncoTargets and Therapy

Oncology

Pharmacology

2014

English

Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population

Archivos de Bronconeumologia

Pulmonary

Respiratory Medicine

2018

English

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

Journal of Thoracic Oncology

English

P3.01-39 Analysis of Acquired EGFR T790M Mutation in Patients With Non-Small Cell Lung Cancer Who Received Icotinib Progress

Journal of Thoracic Oncology

English

P3.01-45 Multifactorial Gene Alterations in EGFR Bypass Pathway Are Induced by Afatinib in T790m-Mutant NSCLC Resistant to Osmertinib

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Pradhan

P3.01-06 Concomitant Plasma-Genotyped T790M Positivity and Small Cell Carcinoma Transformation in EGFR-Mutated NSCLC

(173) Neuropathic Pain Creates an Enduring Deficit in Prefrontal Cortex-Dependent Behavioral Performance That Is Resistant to Gabapentin Treatment but Reversed by Metformin

Related publications

Squamous Cell Carcinoma “Transformation” Concurrent With Secondary T790M Mutation in Resistant EGFR -Mutated Adenocarcinomas

P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC

P3.01-11 Depression and Inflammation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer

P2.13-13 Real-World Study of Osimertinib in EGFR T790m-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis

Primary Concomitant EGFR T790M Mutation Predicted Worse Prognosis in Non-Small Cell Lung Cancer Patients

Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

P3.01-39 Analysis of Acquired EGFR T790M Mutation in Patients With Non-Small Cell Lung Cancer Who Received Icotinib Progress

P3.01-45 Multifactorial Gene Alterations in EGFR Bypass Pathway Are Induced by Afatinib in T790m-Mutant NSCLC Resistant to Osmertinib